Global Intravenous Immunoglobulin (IVIg) Market Insights, Forecast to 2025

Choose Licence

 

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or ?lot? of Intravenous Immunoglobulin. North America region is the largest supplier of intravenous immunoglobulin (IVIg), with a production market share nearly 48% in 2016. Europe is the second largest supplier of intravenous immunoglobulin (IVIg), enjoying production market share nearly 23% in 2016. North America is the largest sales place, with a sales market share nearly 44% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 22%. Market competition is intense. Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. The global Intravenous Immunoglobulin (IVIg) market is valued at 8120 million US$ in 2018 and will reach 12800 million US$ by the end of 2025, growing at a CAGR of 5.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Intravenous Immunoglobulin (IVIg) market based on company, product type, end user and key regions. This report studies the global market size of Intravenous Immunoglobulin (IVIg) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intravenous Immunoglobulin (IVIg) in these regions. This research report categorizes the global Intravenous Immunoglobulin (IVIg) market by top players/brands, region, type and end user. This report also studies the global Intravenous Immunoglobulin (IVIg) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company: Baxter Grifols CSL Octapharma Biotest Kedrion Hualan Bio CNBG Shanghai RAAS CBPO LFB Group BPL Sichuan Yuanda Shuyang Market size by Product IVIg Liquid IVIg Powder Market size by End User Immunodeficiency Autoimmune Disease Acute Infection Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Intravenous Immunoglobulin (IVIg) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. To understand the structure of Intravenous Immunoglobulin (IVIg) market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Intravenous Immunoglobulin (IVIg) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of Intravenous Immunoglobulin (IVIg) submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of Intravenous Immunoglobulin (IVIg) are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Bottle). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Intravenous Immunoglobulin (IVIg) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

 

Table of Contents 1 Study Coverage 1.1 Intravenous Immunoglobulin (IVIg) Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Product 1.4.2 IVIg Liquid 1.4.3 IVIg Powder 1.5 Market by End User 1.5.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by End User 1.5.2 Immunodeficiency 1.5.3 Autoimmune Disease 1.5.4 Acute Infection 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Intravenous Immunoglobulin (IVIg) Market Size 2.1.1 Global Intravenous Immunoglobulin (IVIg) Revenue 2014-2025 2.1.2 Global Intravenous Immunoglobulin (IVIg) Sales 2014-2025 2.2 Intravenous Immunoglobulin (IVIg) Growth Rate by Regions 2.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Regions 2.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Intravenous Immunoglobulin (IVIg) Sales by Manufacturers 3.1.1 Intravenous Immunoglobulin (IVIg) Sales by Manufacturers 3.1.2 Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers 3.1.3 Global Intravenous Immunoglobulin (IVIg) Market Concentration Ratio (CR5 and HHI) 3.2 Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers 3.2.1 Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2014-2019) 3.2.2 Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers (2014-2019) 3.3 Intravenous Immunoglobulin (IVIg) Price by Manufacturers 3.4 Intravenous Immunoglobulin (IVIg) Manufacturing Base Distribution, Product Types 3.4.1 Intravenous Immunoglobulin (IVIg) Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Intravenous Immunoglobulin (IVIg) Product Type 3.4.3 Date of International Manufacturers Enter into Intravenous Immunoglobulin (IVIg) Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Intravenous Immunoglobulin (IVIg) Sales by Product 4.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Product 4.3 Intravenous Immunoglobulin (IVIg) Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Intravenous Immunoglobulin (IVIg) Breakdown Data by End User 6 North America 6.1 North America Intravenous Immunoglobulin (IVIg) by Countries 6.1.1 North America Intravenous Immunoglobulin (IVIg) Sales by Countries 6.1.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Intravenous Immunoglobulin (IVIg) by Product 6.3 North America Intravenous Immunoglobulin (IVIg) by End User 7 Europe 7.1 Europe Intravenous Immunoglobulin (IVIg) by Countries 7.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Countries 7.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Intravenous Immunoglobulin (IVIg) by Product 7.3 Europe Intravenous Immunoglobulin (IVIg) by End User 8 Asia Pacific 8.1 Asia Pacific Intravenous Immunoglobulin (IVIg) by Countries 8.1.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Countries 8.1.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Intravenous Immunoglobulin (IVIg) by Product 8.3 Asia Pacific Intravenous Immunoglobulin (IVIg) by End User 9 Central & South America 9.1 Central & South America Intravenous Immunoglobulin (IVIg) by Countries 9.1.1 Central & South America Intravenous Immunoglobulin (IVIg) Sales by Countries 9.1.2 Central & South America Intravenous Immunoglobulin (IVIg) Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Intravenous Immunoglobulin (IVIg) by Product 9.3 Central & South America Intravenous Immunoglobulin (IVIg) by End User 10 Middle East and Africa 10.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) by Countries 10.1.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Countries 10.1.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) by Product 10.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) by End User 11 Company Profiles 11.1 Baxter 11.1.1 Baxter Company Details 11.1.2 Company Business Overview 11.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Baxter Intravenous Immunoglobulin (IVIg) Products Offered 11.1.5 Baxter Recent Development 11.2 Grifols 11.2.1 Grifols Company Details 11.2.2 Company Business Overview 11.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Grifols Intravenous Immunoglobulin (IVIg) Products Offered 11.2.5 Grifols Recent Development 11.3 CSL 11.3.1 CSL Company Details 11.3.2 Company Business Overview 11.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2014-2019) 11.3.4 CSL Intravenous Immunoglobulin (IVIg) Products Offered 11.3.5 CSL Recent Development 11.4 Octapharma 11.4.1 Octapharma Company Details 11.4.2 Company Business Overview 11.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Products Offered 11.4.5 Octapharma Recent Development 11.5 Biotest 11.5.1 Biotest Company Details 11.5.2 Company Business Overview 11.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Biotest Intravenous Immunoglobulin (IVIg) Products Offered 11.5.5 Biotest Recent Development 11.6 Kedrion 11.6.1 Kedrion Company Details 11.6.2 Company Business Overview 11.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Products Offered 11.6.5 Kedrion Recent Development 11.7 Hualan Bio 11.7.1 Hualan Bio Company Details 11.7.2 Company Business Overview 11.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Products Offered 11.7.5 Hualan Bio Recent Development 11.8 CNBG 11.8.1 CNBG Company Details 11.8.2 Company Business Overview 11.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2014-2019) 11.8.4 CNBG Intravenous Immunoglobulin (IVIg) Products Offered 11.8.5 CNBG Recent Development 11.9 Shanghai RAAS 11.9.1 Shanghai RAAS Company Details 11.9.2 Company Business Overview 11.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2014-2019) 11.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Products Offered 11.9.5 Shanghai RAAS Recent Development 11.10 CBPO 11.10.1 CBPO Company Details 11.10.2 Company Business Overview 11.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2014-2019) 11.10.4 CBPO Intravenous Immunoglobulin (IVIg) Products Offered 11.10.5 CBPO Recent Development 11.11 LFB Group 11.12 BPL 11.13 Sichuan Yuanda Shuyang 12 Future Forecast 12.1 Intravenous Immunoglobulin (IVIg) Market Forecast by Regions 12.1.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Regions 2019-2025 12.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Regions 2019-2025 12.2 Intravenous Immunoglobulin (IVIg) Market Forecast by Product 12.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Product 2019-2025 12.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Product 2019-2025 12.3 Intravenous Immunoglobulin (IVIg) Market Forecast by End User 12.4 North America Intravenous Immunoglobulin (IVIg) Forecast 12.5 Europe Intravenous Immunoglobulin (IVIg) Forecast 12.6 Asia Pacific Intravenous Immunoglobulin (IVIg) Forecast 12.7 Central & South America Intravenous Immunoglobulin (IVIg) Forecast 12.8 Middle East and Africa Intravenous Immunoglobulin (IVIg) Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Intravenous Immunoglobulin (IVIg) Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Intravenous Immunoglobulin (IVIg) Product Picture Table Intravenous Immunoglobulin (IVIg) Market Segments Table Key Manufacturers Intravenous Immunoglobulin (IVIg) Covered Table Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Product 2019-2025 (K Bottle) & (Million US$) Figure Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Product 2014-2025 Figure IVIg Liquid Product Picture Table Major Manufacturers of IVIg Liquid Figure IVIg Powder Product Picture Table Major Manufacturers of IVIg Powder Table Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by End User 2019-2025 (K Bottle) Figure Immunodeficiency Figure Autoimmune Disease Figure Acute Infection Figure Intravenous Immunoglobulin (IVIg) Report Years Considered Figure Global Intravenous Immunoglobulin (IVIg) Market Size 2014-2025 (Million US$) Figure Global Intravenous Immunoglobulin (IVIg) Sales 2014-2025 (K Bottle) Table Global Intravenous Immunoglobulin (IVIg) Market Size by Regions 2014-2019 (K Bottle) & (Million US$) Table Global Intravenous Immunoglobulin (IVIg) Sales by Regions 2014-2019 (K Bottle) Table Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Regions 2014-2019 Figure Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Regions 2014-2019 Figure 2018 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Regions Table Global Intravenous Immunoglobulin (IVIg) Revenue by Regions 2014-2019 (Million US$) Table Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Regions 2014-2019 Figure Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Regions 2014-2019 Figure 2018 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Regions Table Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2014-2019) (K Bottle) Table Global Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturers (2014-2019) Figure Global Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2014-2019) (Million USD) Table Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers (2014-2019) Figure Intravenous Immunoglobulin (IVIg) Value Share by Manufacturers in 2018 Table Key Manufacturers Intravenous Immunoglobulin (IVIg) Price (2014-2019) (USD/Bottle) Table Intravenous Immunoglobulin (IVIg) Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Intravenous Immunoglobulin (IVIg) Product Type Table Date of International Manufacturers Enter into Intravenous Immunoglobulin (IVIg) Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Intravenous Immunoglobulin (IVIg) Sales by Product (2014-2019) (K Bottle) Table Global Intravenous Immunoglobulin (IVIg) Sales Share by Product (2014-2019) Figure Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Product (2014-2019) Figure Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Product in 2018 Table Global Intravenous Immunoglobulin (IVIg) Revenue by Product (2014-2019) (Million US$) Table Global Intravenous Immunoglobulin (IVIg) Revenue Share by Product (2014-2019) Figure Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Product (2014-2019) Figure Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Product in 2018 Table Intravenous Immunoglobulin (IVIg) Price by Product 2014-2019 (USD/Bottle) Table Global Intravenous Immunoglobulin (IVIg) Sales by End User (2014-2019) (K Bottle) Table Global Intravenous Immunoglobulin (IVIg) Sales Share by End User (2014-2019) Figure Global Sales Intravenous Immunoglobulin (IVIg) Market Share by End User (2014-2019) Figure Global Sales Intravenous Immunoglobulin (IVIg) Market Share by End User in 2018 Figure North America Intravenous Immunoglobulin (IVIg) Sales Growth Rate 2014-2019 (K Bottle) Figure North America Intravenous Immunoglobulin (IVIg) Revenue Growth Rate 2014-2019 (Million US$) Table North America Intravenous Immunoglobulin (IVIg) Sales by Countries (2014-2019) (K Bottle) Table North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries (2014-2019) Figure 2018 North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries Table North America Intravenous Immunoglobulin (IVIg) Revenue by Countries (2014-2019) (Million US$) Table North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries (2014-2019) Figure 2018 North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries Figure United States Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure United States Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (K Bottle) Figure Canada Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure Canada Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure Mexico Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Table North America Intravenous Immunoglobulin (IVIg) Sales by Product (2014-2019) (K Bottle) Table North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Product (2014-2019) Figure 2018 North America Intravenous Immunoglobulin (IVIg) Market Share by Product Table North America Intravenous Immunoglobulin (IVIg) Sales by End User (2014-2019) (K Bottle) Table North America Intravenous Immunoglobulin (IVIg) Sales Market Share by End User (2014-2019) Figure 2018 North America Intravenous Immunoglobulin (IVIg) Market Share by End User Figure Europe Intravenous Immunoglobulin (IVIg) Sales Growth Rate 2014-2019 (K Bottle) Figure Europe Intravenous Immunoglobulin (IVIg) Revenue Growth Rate 2014-2019 (Million US$) Table Europe Intravenous Immunoglobulin (IVIg) Sales by Countries (2014-2019) (K Bottle) Table Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries (2014-2019) Figure 2018 Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries Table Europe Intravenous Immunoglobulin (IVIg) Revenue by Countries (2014-2019) (Million US$) Table Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries Figure Germany Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure Germany Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Figure France Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure France Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Figure UK Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure UK Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure Italy Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure Russia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Table Europe Intravenous Immunoglobulin (IVIg) Sales by Product (2014-2019) (K Bottle) Table Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Product (2014-2019) Figure 2018 Europe Intravenous Immunoglobulin (IVIg) Market Share by Product Table Europe Intravenous Immunoglobulin (IVIg) Sales by End User (2014-2019) (K Bottle) Table Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by End User (2014-2019) Figure 2018 Europe Intravenous Immunoglobulin (IVIg) Market Share by End User Figure Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Growth Rate 2014-2019 (K Bottle) Figure Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Countries (2014-2019) (K Bottle) Table Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries Table Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries Figure China Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure China Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure Japan Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure Korea Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Figure India Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure India Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure Australia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure Indonesia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure Malaysia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure Philippines Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure Thailand Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure Vietnam Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure Singapore Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Product (2014-2019) (K Bottle) Table Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Share by Product Table Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by End User (2014-2019) (K Bottle) Table Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Share by End User Figure Central & South America Intravenous Immunoglobulin (IVIg) Sales Growth Rate 2014-2019 (K Bottle) Figure Central & South America Intravenous Immunoglobulin (IVIg) Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Intravenous Immunoglobulin (IVIg) Sales by Countries (2014-2019) (K Bottle) Table Central & South America Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries Table Central & South America Intravenous Immunoglobulin (IVIg) Revenue by Countries (2014-2019) (Million US$) Table Central & South America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries Figure Brazil Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure Brazil Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure Argentina Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Intravenous Immunoglobulin (IVIg) Sales by Product (2014-2019) (K Bottle) Table Central & South America Intravenous Immunoglobulin (IVIg) Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Intravenous Immunoglobulin (IVIg) Market Share by Product Table Central & South America Intravenous Immunoglobulin (IVIg) Sales by End User (2014-2019) (K Bottle) Table Central & South America Intravenous Immunoglobulin (IVIg) Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Intravenous Immunoglobulin (IVIg) Market Share by End User Figure Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Growth Rate 2014-2019 (K Bottle) Figure Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Countries (2014-2019) (K Bottle) Table Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries Table Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries Figure GCC Countries Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure GCC Countries Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure Turkey Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure Egypt Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2014-2019) (K Bottle) Figure South Africa Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Product (2014-2019) (K Bottle) Table Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Share by Product Table Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by End User (2014-2019) (K Bottle) Table Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Share by End User Table Baxter Company Details Table Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2014-2019) Table Baxter Recent Development Table Grifols Company Details Table Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2014-2019) Table Grifols Recent Development Table CSL Company Details Table CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2014-2019) Table CSL Recent Development Table Octapharma Company Details Table Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2014-2019) Table Octapharma Recent Development Table Biotest Company Details Table Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2014-2019) Table Biotest Recent Development Table Kedrion Company Details Table Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2014-2019) Table Kedrion Recent Development Table Hualan Bio Company Details Table Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2014-2019) Table Hualan Bio Recent Development Table CNBG Company Details Table CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2014-2019) Table CNBG Recent Development Table Shanghai RAAS Company Details Table Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2014-2019) Table Shanghai RAAS Recent Development Table CBPO Company Details Table CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2014-2019) Table CBPO Recent Development Table LFB Group Company Details Table BPL Company Details Table Sichuan Yuanda Shuyang Company Details Table Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Regions 2019-2025 (K Bottle) Table Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Regions 2019-2025 Table Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Regions 2019-2025 Table Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Product 2019-2025 (K Bottle) Table Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Product 2019-2025 Table Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Product 2019-2025 (Million US$) Table Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Product 2019-2025 Table Global Intravenous Immunoglobulin (IVIg) Sales Forecast by End User 2019-2025 (K Bottle) Table Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by End User 2019-2025 Figure North America Intravenous Immunoglobulin (IVIg) Sales Growth Rate Forecast (2019-2025) (K Bottle) Figure North America Intravenous Immunoglobulin (IVIg) Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Intravenous Immunoglobulin (IVIg) Sales Growth Rate Forecast (2019-2025) (K Bottle) Figure Europe Intravenous Immunoglobulin (IVIg) Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Growth Rate Forecast (2019-2025) (K Bottle) Figure Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Intravenous Immunoglobulin (IVIg) Sales Growth Rate Forecast (2019-2025) (K Bottle) Figure Central & South America Intravenous Immunoglobulin (IVIg) Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Growth Rate Forecast (2019-2025) (K Bottle) Figure Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Intravenous Immunoglobulin (IVIg) Value Chain Table Intravenous Immunoglobulin (IVIg) Customers List Table Intravenous Immunoglobulin (IVIg) Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Other Reports by QY Research

Global Medical Contract Manufacturing Market Size, Status and Forecast 2019-2025

In 2018, the global Medical Contract Manufacturing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Medical Contract Manufacturing ...

Global Water-based Acrylic Enamel Paints Market Insights, Forecast to 2025

Global Water-based Acrylic Enamel Paints market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the f...

Global Acrylic Enamels Market Insights, Forecast to 2025

Global Acrylic Enamels market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to ...

Global Water Based Enamels Market Insights, Forecast to 2025

Global Water Based Enamels market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period...

Global Vitamin Tonics Market Insights, Forecast to 2025

The global Vitamin Tonics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Vitamin...

New Pharmaceuticals and Healthcare Reports